federal_register: 01-9873
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01-9873 | Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents; Confirmation of Effective Date | Rule | The Food and Drug Administration (FDA) is confirming the effective date of June 11, 2001, for the direct final rule that appeared in the Federal Register of December 12, 2000 (65 FR 77497). The direct final rule rule amends the biologics regulations applicable to microbiological controls for licensed Anti-Human Globulin and Blood Grouping Reagents by removing the requirement that these products be sterile. This document confirms the effective date of the direct final rule. | 2001-04-23 | 2001 | 4 | https://www.federalregister.gov/documents/2001/04/23/01-9873/revision-to-requirements-for-licensed-anti-human-globulin-and-blood-grouping-reagents-confirmation | https://www.govinfo.gov/content/pkg/FR-2001-04-23/pdf/01-9873.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is confirming the effective date of June 11, 2001, for the direct final rule that appeared in the Federal Register of December 12, 2000 (65 FR 77497). The direct final rule rule amends the biologics regulations... |